Shandong Jincheng Pharmaceutical Group Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001500
  • SHE: 300233
CNY
13.78
-0.02 (-0.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
696.82
750.42
804.90
571.78
629.60
712.67
858.07
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
696.82
750.42
804.90
571.78
629.60
712.67
858.07
Raw Material Cost
475.38
521.28
549.15
393.96
421.62
503.26
545.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.03
1.99
2.29
2.47
2.69
3.36
3.93
Selling and Distribution Expenses
124.09
115.61
122.12
148.67
163.86
140.06
182.37
Other Expenses
2.46
2.22
6.07
2.19
2.82
1.93
3.41
Total Expenditure (Excl Depreciation)
626.12
661.09
734.30
566.95
616.40
665.98
765.48
Operating Profit (PBDIT) excl Other Income
70.7
89.3
70.6
4.8
13.200000000000001
46.7
92.6
Other Income
74.64
5.22
7.24
7.65
5.21
8.82
14.92
Operating Profit (PBDIT)
180.38
159.46
112.68
76.45
92.51
132.23
154.95
Interest
2.03
1.99
2.29
2.47
2.69
3.36
3.93
Exceptional Items
0.03
-0.15
0.02
0.04
-0.14
-0.00
0.39
Gross Profit (PBDT)
221.45
229.14
255.75
177.83
207.97
209.41
313.02
Depreciation
81.10
81.10
82.86
82.86
79.48
79.48
79.92
Profit Before Tax
97.29
76.23
27.55
-8.84
10.20
49.39
71.50
Tax
14.74
17.15
18.77
2.16
1.32
13.50
25.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
81.08
57.79
12.61
-11.81
8.33
35.05
45.73
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
81.08
57.79
12.61
-11.81
8.33
35.05
45.73
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.40
1.22
-3.93
0.44
0.34
1.24
-0.09
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
82.48
59.01
8.68
-11.37
8.67
36.30
45.63
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,746.43
3,722.52
3,663.39
3,650.22
3,697.52
3,747.01
3,766.98
Earnings per share (EPS)
0.21
0.15
0.03
-0.03
0.02
0.09
0.12
Diluted Earnings per share
0.21
0.15
0.03
-0.03
0.02
0.09
0.12
Operating Profit Margin (Excl OI)
3.54%
9.75%
2.8%
-2.46%
1.24%
6.16%
7.01%
Gross Profit Margin
25.6%
20.96%
13.72%
12.94%
14.24%
18.08%
17.65%
PAT Margin
11.64%
7.7%
1.57%
-2.06%
1.32%
4.92%
5.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -7.14% vs -6.77% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 39.83% vs 578.16% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -31.45% vs 46.30% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -13.04% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Shandong Jincheng Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
696.82
0
696.82
Other Operating Income
0.00
0.00
0.00
Total Operating income
696.82
0
696.82
Raw Material Cost
475.38
0
475.38
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.03
0
2.03
Selling and Distribution Expenses
124.09
0
124.09
Other Expenses
2.46
0.00
2.46
Total Expenditure (Excl Depreciation)
626.12
0
626.12
Operating Profit (PBDIT) excl Other Income
70.70
0.00
70.70
Other Income
74.64
0
74.64
Operating Profit (PBDIT)
180.38
0
180.38
Interest
2.03
0
2.03
Exceptional Items
0.03
0
0.03
Gross Profit (PBDT)
221.45
0
221.45
Depreciation
81.10
0
81.10
Profit Before Tax
97.29
0
97.29
Tax
14.74
0
14.74
Provisions and contingencies
0
0
0.00
Profit After Tax
81.08
0
81.08
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
81.08
0
81.08
Share in Profit of Associates
0
0
0.00
Minority Interest
1.40
0
1.40
Other related items
0.00
0.00
0.00
Consolidated Net Profit
82.48
0
82.48
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,746.43
0
3,746.43
Earnings per share (EPS)
0.21
0
0.21
Diluted Earnings per share
0.21
0
0.21
Operating Profit Margin (Excl OI)
3.54%
0%
0.00
3.54%
Gross Profit Margin
25.60%
0%
0.00
25.60%
PAT Margin
11.64%
0%
0.00
11.64%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 69.68 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -7.14% vs -6.77% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 10.67% vs -23.86% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.25 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 39.83% vs 578.16% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 848.28% vs -82.53% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.57 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -31.45% vs 46.30% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 21.08% vs -27.43% in Jun 2025

Quarterly - Interest
Interest 0.20 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -13.04% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -25.93% vs -48.08% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.54%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025